World Health Organization: Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser, 2000; 894:i–xii1–253.
2.
MokdadAH, BowmanBA, FordES, VinicorF. The continuing epidemics of obesity and diabetes in the United States. JAMA, 2001; 286:1195–1200.
3.
CDC Behavioral Risk Factor Surveillance System. Prevalence of obesity among U.S. adults. 2011. www.cdc.gov/obesity/data/adult.html. 2013 May 23.
4.
ØstbyeT, YarnallKSH, KrauseKM, PollackKI, GradisonM, MichenerJL. Is there time for management of patients with chronic diseases in primary care?Ann Fam Med, 2005; 3:209–214.
Diabetes Control and Complications Trial (DCCT): results of feasibility study. The DCCT Research Group. Diabetes Care, 1987; 10:1–19.
7.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. TamborlaneWV, BeckRW, BodeBW, BuckinghamB, ChaseHP, ClemonsR, Fiallo-ScharerR, FoxLA, GilliamLK, HirschIB, HuangES, KollmanC, KowalskiAJ, LaffelL, LawrenceJM, LeeJ, MaurasN, O'GradyM, RuedyKJ, TanseyM, TsalikianE, WeinzimerS, WilsonDM, WolpertH, WysockiT, XingD. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med, 2008; 359:1464–1476.
8.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial. Diabetes Care, 2010; 33:17–22.
9.
GargSK, ReedK, GreyJ, WestermanA. Possibly impacts of new accuracy standards of self-monitoring of blood glucose. US Endocrinol, 2013; 9:26–29.
GargSK, VoelmleMK, BeatsonCR, MillerHA, CrewLB, FresonBJ, HazenfieldRM. Use of continuous glucose monitoring in subjects with type 1 diabetes on multiple daily injections versus continuous subcutaneous insulin infusion therapy. Diabetes Care, 2011; 34:574–579.
BlevinsTC, BodeBW, GargSK, GrunbergerG, HirschIB, JovanovicL, NardacciE, OrzeckEA, RobertsVL, TamborlaneWV. AACE Continuous Glucose Monitoring Task Force: Statement by the American Association of Clinical Endocrinologists Consensus Panel on continuous glucose monitoring. Endocr Pract, 2010; 16:730–745.
15.
GargS. Rationale for the use of insulin pumps, continuous glucose monitoring in adult patients. Endocr Pract, 2012; 18,Suppl 2:10–12.
16.
McGlynnEA, AschSM, AdamsJ, KeeseyJ, HicksJ, DecristofaroA, KerrEA. The quality of health care delivered to adults in the United States. N Engl J Med, 2003; 348:2635–2645.
BergenstalRM, AhmannAJ, BaileyT, BeckRW, BuckinghamB, DeebL, DolinR, GargSK, GolandR, HirschI, KlonoffDC, KrugerDF, MatfinG, MazzeR, ParkinC, PetersA, Rodriguez, SoutherlandP, StrockES, TamborlaneW, WesleyDM. Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in type 1 diabetes: the ambulatory glucose profile (AGP)Diabetes Technol Ther, 2013; 15:198–211.
19.
VigerskyRA, FondaSJ, ChellappaM, WalkerMS, EhrhardtNM. Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes. Diabetes Care, 2012; 35:32–38.
